11475269

Source:http://linkedlifedata.com/resource/pubmed/id/11475269

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:11475269	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:11475269	lifeskim:mentions	umls-concept:C0011860	lld:lifeskim
pubmed-article:11475269	lifeskim:mentions	umls-concept:C0031327	lld:lifeskim
pubmed-article:11475269	lifeskim:mentions	umls-concept:C0851347	lld:lifeskim
pubmed-article:11475269	lifeskim:mentions	umls-concept:C0246689	lld:lifeskim
pubmed-article:11475269	lifeskim:mentions	umls-concept:C0678790	lld:lifeskim
pubmed-article:11475269	pubmed:issue	3	lld:pubmed
pubmed-article:11475269	pubmed:dateCreated	2001-7-27	lld:pubmed
pubmed-article:11475269	pubmed:abstractText	The pharmacodynamics and dose-response relationship of repaglinide, a novel oral hypoglycemic agent, were evaluated in steady-state treatment of patients with type 2 diabetes.	lld:pubmed
pubmed-article:11475269	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:language	eng	lld:pubmed
pubmed-article:11475269	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:11475269	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11475269	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:11475269	pubmed:issn	1520-9156	lld:pubmed
pubmed-article:11475269	pubmed:author	pubmed-author:GoldbergR BRB	lld:pubmed
pubmed-article:11475269	pubmed:author	pubmed-author:HuangW CWC	lld:pubmed
pubmed-article:11475269	pubmed:author	pubmed-author:SchwartzS LSL	lld:pubmed
pubmed-article:11475269	pubmed:author	pubmed-author:MarburyT CTC	lld:pubmed
pubmed-article:11475269	pubmed:author	pubmed-author:GrafR JRJ	lld:pubmed
pubmed-article:11475269	pubmed:author	pubmed-author:WestonII	lld:pubmed
pubmed-article:11475269	pubmed:author	pubmed-author:PolvinoWW	lld:pubmed
pubmed-article:11475269	pubmed:author	pubmed-author:StrangePP	lld:pubmed
pubmed-article:11475269	pubmed:issnType	Print	lld:pubmed
pubmed-article:11475269	pubmed:volume	1	lld:pubmed
pubmed-article:11475269	pubmed:owner	NLM	lld:pubmed
pubmed-article:11475269	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:11475269	pubmed:pagination	247-56	lld:pubmed
pubmed-article:11475269	pubmed:dateRevised	2011-11-17	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:meshHeading	pubmed-meshheading:11475269...	lld:pubmed
pubmed-article:11475269	pubmed:year	1999	lld:pubmed
pubmed-article:11475269	pubmed:articleTitle	Pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in type 2 diabetes.	lld:pubmed
pubmed-article:11475269	pubmed:affiliation	Novo Nordisk Pharmaceuticals, Inc., Princeton, New Jersey, USA. pstr@nnpi.com	lld:pubmed
pubmed-article:11475269	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:11475269	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:11475269	pubmed:publicationType	Comparative Study	lld:pubmed
pubmed-article:11475269	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:11475269	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:11475269	pubmed:publicationType	Multicenter Study	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11475269	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11475269	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11475269	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11475269	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11475269	lld:pubmed